Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1038/s41577-020-00434-6

http://scihub22266oqcxt.onion/10.1038/s41577-020-00434-6
suck pdf from google scholar
32887954!7472682!32887954
unlimited free pdf from europmc32887954    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmid32887954      Nat+Rev+Immunol 2020 ; 20 (10): 615-632
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Immunological considerations for COVID-19 vaccine strategies #MMPMID32887954
  • Jeyanathan M; Afkhami S; Smaill F; Miller MS; Lichty BD; Xing Z
  • Nat Rev Immunol 2020[Oct]; 20 (10): 615-632 PMID32887954show ga
  • The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the most formidable challenge to humanity in a century. It is widely believed that prepandemic normalcy will never return until a safe and effective vaccine strategy becomes available and a global vaccination programme is implemented successfully. Here, we discuss the immunological principles that need to be taken into consideration in the development of COVID-19 vaccine strategies. On the basis of these principles, we examine the current COVID-19 vaccine candidates, their strengths and potential shortfalls, and make inferences about their chances of success. Finally, we discuss the scientific and practical challenges that will be faced in the process of developing a successful vaccine and the ways in which COVID-19 vaccine strategies may evolve over the next few years.
  • |Antibodies, Viral/*biosynthesis[MESH]
  • |Betacoronavirus/drug effects/*immunology/pathogenicity[MESH]
  • |COVID-19[MESH]
  • |COVID-19 Vaccines[MESH]
  • |Clinical Trials as Topic[MESH]
  • |Coronavirus Infections/epidemiology/immunology/*prevention & control/virology[MESH]
  • |Genetic Vectors/chemistry/immunology[MESH]
  • |Humans[MESH]
  • |Immunity, Herd/drug effects[MESH]
  • |Immunity, Innate/drug effects[MESH]
  • |Immunization Schedule[MESH]
  • |Immunogenicity, Vaccine[MESH]
  • |Pandemics/*prevention & control[MESH]
  • |Patient Safety[MESH]
  • |Pneumonia, Viral/epidemiology/immunology/*prevention & control/virology[MESH]
  • |SARS-CoV-2[MESH]
  • |Severe Acute Respiratory Syndrome/*epidemiology/immunology/*prevention & control/virology[MESH]
  • |Vaccines, Attenuated[MESH]
  • |Vaccines, DNA[MESH]
  • |Vaccines, Subunit[MESH]
  • |Vaccines, Virus-Like Particle[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box